New drug duo shows promise for hard-to-treat blood cancer
NCT ID NCT02942290
First seen May 21, 2026 · Last updated May 21, 2026
Summary
This early-stage study tests a combination of two drugs, venetoclax and azacitidine, in people with a serious form of myelodysplastic syndromes (MDS) who have not had prior treatment. The goal is to find the safest dose and see how well the drugs work together to control the disease. About 129 adults with higher-risk MDS are taking part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MYELODYSPLASTIC SYNDROMES (MDS) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Austin Health /ID# 154955
Heidelberg, Victoria, 3084, Australia
-
Calvary Mater Newcastle /ID# 154957
Waratah, New South Wales, 2298, Australia
-
Centre Hospitalier Universitaire de Nantes, Hotel Dieu -HME /ID# 153828
Nantes, Pays de la Loire Region, 44000, France
-
Columbia University Medical Center /ID# 153661
New York, New York, 10032-3729, United States
-
Concord Repatriation General Hospital /ID# 154958
Concord, New South Wales, 2139, Australia
-
Dana-Farber Cancer Institute /ID# 152735
Boston, Massachusetts, 02215, United States
-
Duplicate_Azienda Ospedaliero-Universitaria Policlinico Umberto I /ID# 153764
Rome, Roma, 00161, Italy
-
Duplicate_IRCCS AOU di Bologna - Policlinico Sant'Orsola-Malpighi /ID# 153763
Bologna, Emilia-Romagna, 40138, Italy
-
Duplicate_Princess Alexandra Hospital /ID# 154990
Woolloongabba, Queensland, 4102, Australia
-
Duplicate_St. Vincent's Hospital, Darlinghurst /ID# 222846
Darlinghurst, New South Wales, 2010, Australia
-
Duplicate_Universitaetsklinikum Carl Gus /ID# 153958
Dresden, Saxony, 01307, Germany
-
Duplicate_University of Arizona Cancer Center - North Campus /ID# 154155
Tucson, Arizona, 85719-1478, United States
-
Fiona Stanley Hospital /ID# 222847
Murdoch, Western Australia, 6150, Australia
-
Hôpital Saint-Louis /ID# 153827
Paris, 75010, France
-
Juravinski Cancer Centre /ID# 152947
Hamilton, Ontario, L8V 1C3, Canada
-
King's College Hospital NHS Foundation Trust /ID# 156489
London, SE5 9RS, United Kingdom
-
Klinikum rechts der Isar /ID# 153139
Munich, Bavaria, 81675, Germany
-
Liverpool Hospital /ID# 222410
Liverpool, New South Wales, 2170, Australia
-
Norfolk and Norwich University Hospitals NHS Foundation Trust /ID# 156492
Norwich, Norfolk, NR4 7UY, United Kingdom
-
Oregon Medical Research Center /ID# 152734
Portland, Oregon, 97239, United States
-
Oxford University Hospitals NHS Foundation Trust /ID# 222567
Oxford, Oxfordshire, OX3 9DU, United Kingdom
-
St George Hospital /ID# 154954
Kogarah, New South Wales, 2217, Australia
-
Tennessee Oncology-Nashville Centennial /ID# 222769
Nashville, Tennessee, 37203-1632, United States
-
The Alfred Hospital /ID# 154956
Melbourne, Victoria, 3004, Australia
-
The University of Chicago Medical Center /ID# 153673
Chicago, Illinois, 60637-1443, United States
-
Tufts Medical Center /ID# 153672
Boston, Massachusetts, 02111-1552, United States
-
UT MD Anderson Cancer Center /ID# 153809
Houston, Texas, 77030, United States
-
Universitaetsklinikum Halle (Saale) /ID# 153760
Halle, 06120, Germany
-
Universitaetsklinikum Koeln /ID# 153141
Cologne, North Rhine-Westphalia, 50937, Germany
-
Universitaetsklinikum Leipzig /ID# 153142
Leipzig, Saxony, 04103, Germany
-
Universitatsklinikum Mannheim /ID# 153140
Mannheim, Baden-Wurttemberg, 68167, Germany
-
University Hospitals Birmingham NHS Foundation Trust /ID# 158810
Birmingham, B15 2TH, United Kingdom
-
University of Maryland, Baltimore /ID# 153669
Baltimore, Maryland, 21201, United States
-
University of Pittsburgh MC /ID# 153662
Pittsburgh, Pennsylvania, 15260, United States
-
Vanderbilt University Medical Center /ID# 152738
Nashville, Tennessee, 37232-0011, United States
-
Washington University-School of Medicine /ID# 153671
St Louis, Missouri, 63110, United States
-
Weill Cornell Medical College /ID# 155524
New York, New York, 10065, United States
Conditions
Explore the condition pages connected to this study.